Description:

AMC-061 Response Evaluation Form (R61) Sunitinib Malate in Treating HIV-Positive Patients With Cancer Undergoing Highly Active Antiretroviral Therapy https://clinicaltrials.gov/ct2/show/NCT00890747

Link:

https://clinicaltrials.gov/ct2/show/NCT00890747

Keywords:
Versions (2) ▾
  1. 8/26/12
  2. 6/24/17
Uploaded on:

June 24, 2017

DOI:
No DOI assigned. To request one pleaselog in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

HIV Cancer Sunitinib NCT00890747 AMC-061

This form is to be updated at each response assessment time point defined in the protocol. Please see protocol for guidelines for response evaluation

Header Module
mm/dd/yyyy
Complete Response
mm/dd/yyyy
mm/dd/yyyy
Morphologic Complete Remission
mm/dd/yyyy
mm/dd/yyyy
Complete Response, Unconfirmed
mm/dd/yyyy
mm/dd/yyyy
Morphologic Complete Remission With Incomplete Blood Count Recovery
mm/dd/yyyy
mm/dd/yyyy
Partial Response
mm/dd/yyyy
mm/dd/yyyy
Progressive Disease
mm/dd/yyyy